Different fat depots are distinct mini-organs

Current Opinion in Endocrinology and Diabetes

Volumn 8, Issue 5, 2001, Pages 227-234

  Tchkonia, T ^a   Karagiannides, I ^a   Armour Forse, R ^a   Kirkland, J L ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; GLUCOCORTICOID; LEPTIN; THIAZOLE DERIVATIVE;

ADIPOSE TISSUE CELL; ATHEROSCLEROSIS; BODY FAT; DIABETES MELLITUS; HUMAN; INNERVATION; LIPID STORAGE; MORBIDITY; OBESITY; REVIEW; RISK FACTOR;

EID: 0034808972     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-200110000-00001     Document Type: Review

References (110)

1. Genetic and nongenetic determinants of regional fat distribution
2. Relation of body fat distribution to metabolic complications of obesity
3. Regional adiposity and morbidity
4. Central obesity and free fatty acid metabolism
5. Impact of obesity on men and women: Importance of regional adipose tissue distribution
6. The insulin resistance-dyslipidemic syndrome of visceral obesity: Effect on patients' risk
7. Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow up of participants in the population study of women in Gothenberg, Sweden
8. Regional obesity and risk of cardiovascular disease: The Framingham study
9. The association of body fat distribution with hypertension, hypertensive heart disease, coronary heart disease, diabetes and cardiovascular risk factors in men and women aged 18-79 years
10. Relation of anthropometric measurements of body fat distribution to metabolic profile in premenopausal women
11. Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity
12. Role of insulin resistance in human disease
13. Obesity, body fat distribution, insulin sensitivity and islet β-cell function as explanations for metabolic diversity
14. Visceral obesity in men: Associations with glucose tolerance, plasma insulin, and lipoprotein levels
15. Visceral obesity: A "civilization syndrome"
16. The visceral adiposity syndrome in Japanese-American men
17. Relationships of generalized and regional adiposity to insulin sensitivity in men
18. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity
19. Subdivisions of subcutaneous abdominal tissue and insulin resistance
20. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity
21. Systemic resistance to the antilipolytic effect of insulin in black and white women with visceral obesity
22. Intra-abdominal fat is a major contributor to insulin sensitivity in both lean and obese subjects
23. Surgical removal of visceral fat reverses hepatic insulin resistance
24. A review of the association between abdominal fat distribution, health outcome measures, and modifiable risk factors
25. Psychosocial and socio-economic factors in women and their relation to obesity and regional body fat distribution
26. Smoking initiation and cessation in relation to body fat distribution based on data from a study of Swedish women
27. Lipodystrophies
28. Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes
29. Effect of troglitazone on body fat distribution in type 2 diabetic patients
30. Quantification of adipose tissue by MRI: Relation with anthropometric variables
31. Adipose tissue distribution measured by magnetic resonance imaging in obese women
32. Long-term testosterone administration increases visceral fat in female to male transsexuals
33. Effects of testosterone and estrogens on deltoid and trochanter adipocytes in two cases of transsexualism
34. The perils of portliness; causes and consequences of visceral adiposity
35. Major gene for abdominal visceral fat area in the Quebec family study
36. Generalized lipodystrophy, congenital and acquired (lipoatrophy)
37. A gene for congenital generalized lipodystrophy maps to human chromosome 9q34
38. Disruption of the relation between fat content and leptin levels with aging in humans
39. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance
40. High-fat feeding induces tissue-specific alteration in proportion of activated insulin receptors in rats
41. Effects of surgically induced weight loss on urinary bladder pressure, sagittal abdominal diameter and obesity co-morbidities
42. Preadipocyte function and aging: Links between age-related changes in cell dynamics and altered fat cell function
43. Qualitative regional differences in adipose tissue growth and cellularity in male Wistar rats fed ad libitum
44. Suction lipectomy: Outcome relates to region-specific lipoprotein lipase activity and internal weight change
45. The occurrence of breast enlargement in females following liposuction
46. Metabolic response to localized surgical fat removal in non-obese women
47. The regulation of total body fat: Lessons learned from lipectomy studies
48. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2
49. The degree of masculine differentiation of obesities, a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease
50. Regional adiposity in man
51. 2
52. Regional differences in the control of lipolysis in human adipose tissue
53. Differences in lipolysis between human subcutaneous and omental adipose tissues
54. Influence of body fat distribution on free fatty acid metabolism in obesity
55. The morphology and metabolism of intraabdominal adipose tissue in man
56. Health consequences of fat distribution
57. Regulation of lipolysis in humans; pathophysiologic modulation in obesity, diabetes, and hyperlipidemia
58. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells
59. Beta-adrenoceptor expression in human fat cells from different regions
60. Alpha 2A-adrenergic regulation of cyclic AMP accumulation and lipolysis in human omental and subcutaneous adipocytes
61. Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis
62. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: Relation to insulin receptor phosphorylation and intracellular signaling through the insulin receptor substrate-1 pathway
63. Depot-specific differences in adipose tissue gene expression in lean and obese subjects
64. Fat depot origin affects fatty acid handling in cultured rat and human preadipocytes
65. Relation of body fat distribution to the metabolic clearance of insulin in obese women
66. Splanchnic insulin metabolism in obesity
67. The glucose-fatty acid cycle: Its role in insulin sensitivity
68. Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects
69. The effect of ASP on the adipocyte of the morbidly obese
70. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues
71. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men
72. Steroid hormone receptors in human adipose tissue
73. Does central obesity reflect "Cushing's disease of the omentum"?
74. Regulation of expression of 11 β-hydroxysteroid dehydrogenase type 1 i adipose tissue: Tissue-specific induction by cytokines
75. Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans
76. Depot- and sex-specific differences in human leptin mRNA expression: Implications for the control of regional fat distribution
77. Leptin secretion from subcutaneous and visceral adipose tissue in women
78. Intrinsic site-specific differences in the expression of leptin in adipocytes and its autocrine effects on glucose uptake
79. Leptin concentration in women is influenced by regional distribution of adipose tissue
80. Short term effects of leptin on hepatic gluconeogenesis and in vive insulin action
81. Effects of leptin on insulin sensitivity in normal rats
82. Positional cloning of the mouse obese gene and its human homologue
83. Cholesterol ester transfer protein (CETP) mRNA abundance in human adipose tissue: Relation to cell size and membrane cholesterol content
84. Am J Physiol
85. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue
86. The association of human adipose angiotensinogen gene expression with abdominal fat distribution in obesity
87. Fat pad-specific compensatory mass increases after varying degrees of partial lipectomy in Siberian hamsters
88. Alpha-adrenergic antilipolytic effect of adrenaline in human fat cells of the thigh: Comparison with adrenaline responsiveness of different fat deposits
89. Site- and sex-related differences in adrenoreceptor status of human adipose tissue
90. Norepinephrine inhibits rat preadipocyte proliferation
91. Local sympathetic denervation of white adipose tissue in rats induces preadipocyte proliferation without noticeable changes in metabolism
92. Influence of anatomic site and age on the replication and differentiation of rat adipocyte precursors in culture
93. Adipocyte precursor clones vary in capacity for differentiation
94. Regional variation of adipose differentiation in cultured stromal-vascular cells from the abdominal and femoral adipose tissue of obese women
95. Age, anatomic site, and the replication differentiation of adipocyte precursors
96. Effects of fat depot site on differentiation-dependent gene expression in rat preadipocytes
97. Varying capacities for replication of rat adipocyte precursor clones and adipose tissue growth
98. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation
99. Demonstration of de novo production of preadipo adipocytes in adult rats by biochemical and radioautographic techniques
100. Differentiation of adipocyte precursor cells from obese and nonobese adult women from different adipose tissue sites
101. A novel method for analysis of nuclear receptor function at natural promoters: Peroxisome proliferator-activated receptor gamma agonist actions on ap2 gene expression detected using branched DNA messenger RNA quantitation
102. Human preadipocytes display a depot-specific susceptibility to apoptosis
103. Effect of hypophysectomy on rat preadipocyte replication and differentiation
104. Control of rat preadipocyte adipose conversion by ovarian status: Regional specificity and possible involvement of the mitogen-activated protein kinase-dependent and c-fos signaling pathways
105. Depot-related gene expression in human subcutaneous and omental adipooytes
106. Differential expression of PPAR-gamma1 and gamma2 isoforms in human adipose tissue
107. Altered expression of C/EBP family members results in decreased adipogenesis with aging
108. The role of antidepressants in the treatment of abdominal obesity